NIRG (n = 176) | IRG (n = 183) | ||||
---|---|---|---|---|---|
n | % | n | % | p | |
Sex | |||||
Males | 156 | 88,60% | 105 | 57,40% | 0.005 |
Physical activity | |||||
Sedentary | 105 | 59,70% | 117 | 64,60% | 0.595 |
Active | 71 | 40,30% | 66 | 36,50% | |
Clinical characteristics | |||||
Previous myocardial revascularization | 142 | 81% | 142 | 78% | 0.472 |
Hypertension | 166 | 94% | 179 | 98% | 0.09 |
Type 2 diabetes mellitus | 81 | 46% | 98 | 54% | 0.154 |
Dyslipidemia | 155 | 88% | 161 | 88% | 0.979 |
CVD family history | 131 | 74% | 127 | 69% | 0.299 |
Smoking status | |||||
Current smoker | 11 | 6% | 11 | 6% | 0.864 |
Former smoker | 97 | 55% | 106 | 58% | |
Nonsmoker | 68 | 39% | 66 | 36% | |
Drugs in use | |||||
Acetylsalicylic acid | 165 | 94% | 171 | 93% | 0.905 |
Clopidogrel | 11 | 6% | 20 | 11% | 0.114 |
Beta-blocker | 152 | 86% | 155 | 85% | 0.654 |
Thiazide diuretics | 38 | 22% | 56 | 31% | 0.06 |
ACE inhibitors | 86 | 49% | 88 | 48% | 0.883 |
Angiotensin receptor blockers | 47 | 27% | 64 | 35% | 0.09 |
Calcium channel blockers | 38 | 22% | 63 | 34% | 0.006 |
Statin | 166 | 94% | 164 | 90% | 0.102 |
Metformin | 71 | 40% | 82 | 45% | 0.392 |
Insulin | 23 | 13% | 38 | 21% | 0.05 |